Connection
Naghmehossadat Eshghi to Antibodies, Monoclonal
This is a "connection" page, showing publications Naghmehossadat Eshghi has written about Antibodies, Monoclonal.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.928 |
|
|
|
-
Eshghi N, Lundeen TF, MacKinnon L, Avery R, Kuo PH. 18F-FDG PET/CT for Monitoring Response of Merkel Cell Carcinoma to the Novel Programmed Cell Death Ligand 1 Inhibitor Avelumab. Clin Nucl Med. 2018 May; 43(5):e142-e144.
Score: 0.468
-
Eshghi N, Lundeen TF, Kuo PH. Dynamic Adaptation of Tumor Immune Response With Nivolumab Demonstrated by 18F-FDG PET/CT. Clin Nucl Med. 2018 Feb; 43(2):114-116.
Score: 0.460